In the case of antiphospholipid antibody syndrome, initiation of warfarin therapy can lead to thromboembolism and venous gangrene by similarly suppressing the levels of PC and protein S on top of a preexisting hypercoagulable state [5]. This evidence concerns the gene PROS1 and Thromboembolism.